Related Experiment Videos
Anaphylactoid reaction to atracurium
Canadian Anaesthetists' Society Journal
|September 1, 1986
Summary
Atracurium, an intermediate-acting muscle relaxant, can cause anaphylactoid reactions even at low doses. This case highlights unique patient factors that may predispose individuals to adverse events during anesthesia.
Area of Science:
- Anesthesiology
- Pharmacology
- Clinical Medicine
Background:
- Atracurium is an intermediate-acting neuromuscular blocking agent used in anesthesia.
- It is generally considered to have minimal cardiovascular effects within the clinical dose range.
- Histamine release from atracurium is dose-dependent but typically below the threshold for hemodynamic compromise.
Observation:
- A patient experienced an anaphylactoid reaction following a low dose (0.2 mg/kg) of atracurium.
- This reaction occurred despite the dose being within recommended limits and below the expected threshold for adverse cardiovascular effects.
- The patient exhibited peculiar characteristics that may have contributed to the hypersensitivity reaction.
Findings:
- The case demonstrates that anaphylactoid reactions to atracurium can occur at lower doses than previously suggested.
- Specific patient-related factors, not detailed here, appear to play a crucial role in the development of these reactions.
- The reaction was characterized as anaphylactoid, suggesting a non-IgE mediated hypersensitivity response.
Implications:
- Anesthesiologists should be aware of the potential for atracurium-induced anaphylactoid reactions, even at low doses.
- Further investigation into patient-specific risk factors for atracurium hypersensitivity is warranted.
- This case underscores the importance of vigilance and prompt recognition of adverse drug reactions during surgical procedures.